Alfonso Valencia

2021

• BioFVM-X: An MPI+OpenMP 3-D Simulator for Biological Systems

  G. Saxena, M. Ponce-de-Leon, A. Montagud, D. Vicente Dorca, and A. Valencia
• STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells

  Nucleic Acids Research

  L. Richart, E. Lapi, V. Pancaldi, M. Cuenca-Ardura, E. Carrillo-d Pau, M. Madrid-Mencía, H. Neyret-Kahn, F. Radvanyi, J. Antonio Rodríguez, Y. Cuartero, F. Serra, F. Le Dily, A. Valencia, M. A. Marti-Renom, and F. X. Real
• Computational analysis of sense-antisense chimeric transcripts reveals their potential regulatory features and the landscape of expression in human cells

  NAR Genomics and Bioinformatics

  S. Mukherjee, R. Detroja, D. Balamurali, E. Matveishina, Y. A. Medvedeva, A. Valencia, A. Gorohovski, and M. Frenkel-Morgenstern
• Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer

  Cancers

  J. Forés-Martos, C. Boullosa, D. Rodrigo-Domínguez, J. Sánchez-Valle, B. Suay-García, J. Climent, A. Falcó, A. Valencia, J. Anton Puig-Butillé, S. Puig, and R. Tabarés-Seisdedos
• Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster

  Emerging Microbes & Infections

  M. Brustolin, J. Rodon, M. Luisa Rodr de la Concepción, C. Ávila-Nieto, G. Cantero, M. Pérez, N. Te, M. Noguera-Julian, V. Guallar, A. Valencia, N. Roca, N. Izquierdo-Useros, J. Blanco, B. Clotet, A. Bensaid, J. Carrillo, J. Vergara-Alert, and J. Segalés
• Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies

  Transboundary and Emerging Diseases

  J. Vergara‐Alert, J. Rodon, J. Carrillo, N. Te, N. Izquierdo‐Useros, M. Luisa Rodr de la Concepción, C. Ávila‐Nieto, V. Guallar, A. Valencia, G. Cantero, J. Blanco, B. Clotet, A. Bensaid, and J. Segalés
• Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug

  Frontiers in Pharmacology

  J. Rodon, J. Muñoz-Basagoiti, D. Perez-Zsolt, M. Noguera-Julian, R. Paredes, L. Mateu, C. Quiñones, C. Perez, I. Erkizia, I. Blanco, A. Valencia, V. Guallar, J. Carrillo, J. Blanco, J. Segalés, B. Clotet, J. Vergara-Alert, and N. Izquierdo-Useros
• SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity

  Scientific Reports

  B. Trinité, F. Tarrés-Freixas, J. Rodon, E. Pradenas, V. Urrea, S. Marfil, M. Luisa Rodr de la Concepción, C. Ávila-Nieto, C. Aguilar-Gurrieri, A. Barajas, R. Ortiz, R. Paredes, L. Mateu, A. Valencia, V. Guallar, L. Ruiz, E. Grau, M. Massanella, J. Puig, A. Chamorro, N. Izquierdo-Useros, J. Segalés, B. Clotet, J. Carrillo, J. Vergara-Alert, and J. Blanco
• Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes

  Med

  E. Pradenas, B. Trinité, V. Urrea, S. Marfil, C. Ávila-Nieto, M. Luisa Rodr de la Concepción, F. Tarrés-Freixas, S. Pérez-Yanes, C. Rovirosa, E. Ainsua-Enrich, J. Rodon, J. Vergara-Alert, J. Segalés, V. Guallar, A. Valencia, N. Izquierdo-Useros, R. Paredes, L. Mateu, A. Chamorro, M. Massanella, J. Carrillo, B. Clotet, and J. Blanco
• ELIXIR‐EXCELERATE: establishing Europe's data infrastructure for the life science research of the future

  The EMBO Journal

  J. Harrow, J. Hancock, N. Blomberg, N. Blomberg, S. Brunak, S. Capella-Gutierrez, C. Durinx, C. T. Evelo, C. Goble, I. Gut, J. Ison, T. Keane, B. Leskošek, L. Matyska, J. McEntyre, C. Miguel, A. Navarro, S. Newhouse, T. Nyrönen, P. Palagi, B. Persson, C. Pommier, J. Rambla, M. Roos, G. Rustici, A. Smith, A. Valencia, C. van Gelder, J. Vondrášek, N. Peder Willassen, J. Arenas, H. Parkinson, R. D. Finn, S. Beltran, L. Matalonga, H. Hurst, P. Kersey, I. Lappalainen, P. Kahlem, G. Saunders, S. Sarntivijai, R. Drysdale, J. Tedds, J. Lanfear, and J. Harrow